Covered recipient · General Payments record
JORDAN MICHELENA
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2024
$1,086.10
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.01 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $85.59 | 4 |
| Lilly USA, LLC | $45.34 | 2 |
| Teva Pharmaceuticals USA, Inc. | $30.71 | 1 |
| Alkermes, Inc. | $27.88 | 1 |
| DEXCOM, INC. | $24.54 | 1 |
| Indivior Inc. | $22.72 | 1 |
| SANOFI PASTEUR INC. | $21.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $27.88 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120554485 | CMS |
| Dexcom, Inc. | $24.54 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310737 | CMS |
| Indivior Inc. | $22.72 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144533517 | CMS |
| Lilly USA, LLC | $24.13 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135081580 | CMS |
| Lilly USA, LLC | $21.21 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135082860 | CMS |
| Novo Nordisk Inc | $22.42 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097158160 | CMS |
| Novo Nordisk Inc | $17.48 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097727074 | CMS |
| Novo Nordisk Inc | $21.16 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097094158 | CMS |
| Novo Nordisk Inc | $24.53 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097201650 | CMS |
| SANOFI PASTEUR INC. | $21.23 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128739752 | CMS |
| Teva Pharmaceuticals USA, Inc. | $30.71 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151576693 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.